Ajovy

Ajovy (Fremanezumab) is a prescription medication used for migraine prevention. This subcutaneous injection is designed to reduce the frequency of migraine episodes in eligible patients.

Ajovy is primarily used for the preventive treatment of migraines. It is administered via subcutaneous injection and is intended for adults who experience frequent migraine episodes. The medication works by targeting specific pathways involved in migraine pathogenesis, helping to reduce the number of migraine days per month.

Common effects of Ajovy may include injection site reactions such as redness, swelling, or itching. Some users may also experience fatigue, musculoskeletal pain, or upper respiratory tract infection. These effects are generally mild to moderate and may vary among individuals.

Ajovy should be used under the supervision of a healthcare provider. It is important to inform your healthcare professional about any allergies or medical conditions before starting treatment. The medication should be stored as directed and handled with care to avoid contamination.

Ajovy may interact with other medications, including those that affect the immune system or blood clotting. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol consumption should be moderated while using Ajovy.